SurvivorNet on MSN: 'Very promising': New cancer drug, Plixorafenib, shows promise for hard‑to‑treat brain tumors as FDA speeds its development 'Very promising': New cancer drug, Plixorafenib, shows promise for hard‑to‑treat brain tumors as FDA speeds its development Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can ... Fox News: Woman beats deadly brain cancer with investigational cell therapy: 'Truly amazing' Markets Insider: Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model Medical Xpress: An avatar to study pediatric brain cancer may soon be a reality An avatar to study pediatric brain cancer may soon be a reality Yahoo: Groundbreaking new brain cancer test has an 80% accuracy rate with no false positives Add Yahoo as a preferred source to see more of our stories on Google.
A new brain cancer test using spinal fluid detects tumors with 100% accuracy, offering safer diagnosis and fewer risky biopsies. Groundbreaking new brain cancer test has an 80% accuracy rate with no false positives News Medical: Scientists identify common molecular program across multiple brain tumor types Research uncovering the origin of pineoblastoma, a rare pediatric brain tumor, has also revealed a dependency across multiple brain tumor types that share a similar molecular program. Scientists at St ...
